Search

everythinglearnresearchcommunity

for

Search:↓

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Dupilumab significantly improved a 5-year-old girl's prurigo nodularis without side effects.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

The treatment combination is effective and generally safe for lung cancer.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

Cancer treatments often cause hair loss, and more research is needed to prevent and treat it.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Regulatory T cells adapt to different environments to control inflammation and support tissue repair.

Scalp cooling helps prevent hair loss during chemotherapy, and minoxidil aids regrowth.

Dupilumab effectively improves skin conditions, reduces symptoms, and enhances quality of life in certain dermatological issues.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

A medication for skin rash also unexpectedly treated hair loss in a patient.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

A cancer patient's hair became permanently curly after treatment with nivolumab.